Literature DB >> 3135337

Vancomycin resistance of clinical isolates of lactobacilli.

R E Holliman1, G P Bone.   

Abstract

Strains of lactobacilli were cultured from two patients with clinical evidence of infection. Each isolate was found to be highly resistant to vancomycin but inactivation of the antibiotic could not be demonstrated. Lactobacillus isolates should be regarded as potential pathogens. Reliable vancomycin susceptibility testing is required since susceptibility among Gram-positive bacteria in general should not be assumed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135337     DOI: 10.1016/s0163-4453(88)97676-1

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  13 in total

1.  Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host.

Authors:  S J Antony
Journal:  J Natl Med Assoc       Date:  2000-02       Impact factor: 1.798

2.  Brain abscess due to Wolinella recta and Streptococcus intermedius.

Authors:  T J Marrie; E Kerr
Journal:  Can J Infect Dis       Date:  1990

3.  Clinical and microbiologic characteristics of pediococci.

Authors:  W J Riebel; J A Washington
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 4.  Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.

Authors:  J P Cannon; T A Lee; J T Bolanos; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

5.  Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species.

Authors:  J M Swenson; R R Facklam; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

6.  Isolation of vancomycin-resistant lactobacilli from three neutropenic patients with pneumonia.

Authors:  S Sriskandan; S Lacey; L Fischer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

7.  Lactobacillus species as emerging pathogens in neutropenic patients.

Authors:  C Fruchart; A Salah; C Gray; E Martin; A Stamatoullas; G Bonmarchand; J F Lemeland; H Tilly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

8.  Lactobacillus rhamnosus bacteremia: an emerging clinical entity.

Authors:  F Gouriet; M Million; M Henri; P-E Fournier; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-28       Impact factor: 3.267

9.  Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status.

Authors:  A Felten; C Barreau; C Bizet; P H Lagrange; A Philippon
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Identification of vancomycin-resistant lactic bacteria isolated from humans.

Authors:  T Mackey; V Lejeune; M Janssens; G Wauters
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.